Janux Therapeutics, Inc. (JANX)
13.84
-0.13
(-0.93%)
USD |
NASDAQ |
Mar 06, 16:00
14.00
+0.16
(+1.16%)
After-Hours: 18:19
Janux Therapeutics Cash from Investing (Quarterly) : 29.54M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | -1.458B |
| Eli Lilly & Co. | -2.802B |
| Ionis Pharmaceuticals, Inc. | -419.50M |
| MannKind Corp. | -291.96M |
| EyePoint Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.54M |
| Cash from Financing (Quarterly) | 2.944M |
| Free Cash Flow | -83.28M |
| Free Cash Flow Per Share (Quarterly) | -0.461 |
| Free Cash Flow to Equity (Quarterly) | -28.13M |
| Free Cash Flow to Firm (Quarterly) | -28.65M |
| Free Cash Flow Yield | -9.71% |